To evaluate the efficacy and safety of nafamostat mesylate as an anticoagulant regimen in maintenance hemodialysis (MHD).
30 patients with high risk of bleeding in the department of nephrology, Shanghai fourth people's hospital were selected as the observation group, receiving the anticoagulant regimen of nafamostat mesylate, and 30 patients with MHD were selected as the control group, receiving the anticoagulant regimen of ordinary heparin. Blood routine, liver and kidney function, blood lipid status, compression hemostasis time of arterial puncture point, and activated partial thromboplastin time (APTT), prothrombin time (PT) and thrombin time (TT) in vitro and in vivo were observed before and after MHD in the two groups.
The levels of blood urea and creatinine after MHD in both groups were significantly lower than those before dialysis (P<0.05). In the observation group, APTT index in vivo was not significantly prolonged after HD, but APTT index in vitro was significantly prolonged (P<0.05). In the control group, APTT and TT index in vivo and in vitro were significantly prolonged (P<0.05). In terms of mechanical coagulation observation, the compression hemostasis time of MHD artery puncture in the observation group was significantly shorter than that in the control group (P<0.05).
Nafamostat mesylate is a safe and effective anticoagulant regimen for MHD patients at high risk of bleeding.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |